Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulf Landmesser

Showing results (11-20 of 735) with videos related to

Pageof 74
Sort By:
Deutsche Medizinische Wochenschrift (1946)|April 1, 2015
[Myocardial revascularization: the new European guidelines]Georg Fröhlich, Ulf Landmesser
Arteriosclerosis, Thrombosis, and Vascular Biology|September 17, 2002
Toward understanding of extracellular superoxide dismutase regulation in atherosclerosis: a novel role of uric acid?Ulf Landmesser, Helmut Drexler
Current Heart Failure Reports|March 19, 2013
Current status of cell-based therapy for heart failurePhilipp Jakob, Ulf Landmesser
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|April 8, 2006
Effect of angiotensin II type 1 receptor antagonism on endothelial function: role of bradykinin and nitric oxideUlf Landmesser, Helmut Drexler
Journal of Lipid Research|July 23, 2013
High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular diseaseMeliana Riwanto, Ulf Landmesser
Circulation|July 10, 2023
New Chapter in the PCSK9 Book: Oral Inhibition of PCSK9 Binding to the LDL Receptor With a Macrocyclic PeptideUlf Landmesser, Umidakhon Makhmudova
European Heart Journal|August 31, 2024
Advanced understanding of immune mechanisms in acute myocardial infarction: coronary extracellular vesicles trigger NETosisTeresa Gerhardt, Ulf Landmesser
European Heart Journal|June 26, 2026
PCSK9 inhibition in patients without previous cardiovascular events but at high risk: the earlier the betterDavid Sinning, Ulf Landmesser
Current Cardiology Reports|October 22, 2020
Low-density Lipoprotein-Cholesterol Lowering Strategies for Prevention of Atherosclerotic Cardiovascular Disease: Focus on siRNA Treatment Targeting PCSK9 (Inclisiran)David Sinning, Ulf Landmesser
International Journal of Cardiology|September 7, 2017
Challenges in using high-sensitive troponin reporting in clinical practice-The important role of appropriate use in the context of clinical evaluationMartin Möckel, Ulf Landmesser
Pageof 74

Showing results (11-20 of 735) with videos related to

Sort By:
Pageof 74
Deutsche Medizinische Wochenschrift (1946)|April 1, 2015
[Myocardial revascularization: the new European guidelines]Georg Fröhlich, Ulf Landmesser
Arteriosclerosis, Thrombosis, and Vascular Biology|September 17, 2002
Toward understanding of extracellular superoxide dismutase regulation in atherosclerosis: a novel role of uric acid?Ulf Landmesser, Helmut Drexler
Current Heart Failure Reports|March 19, 2013
Current status of cell-based therapy for heart failurePhilipp Jakob, Ulf Landmesser
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|April 8, 2006
Effect of angiotensin II type 1 receptor antagonism on endothelial function: role of bradykinin and nitric oxideUlf Landmesser, Helmut Drexler
Journal of Lipid Research|July 23, 2013
High density lipoproteins and endothelial functions: mechanistic insights and alterations in cardiovascular diseaseMeliana Riwanto, Ulf Landmesser
Circulation|July 10, 2023
New Chapter in the PCSK9 Book: Oral Inhibition of PCSK9 Binding to the LDL Receptor With a Macrocyclic PeptideUlf Landmesser, Umidakhon Makhmudova
European Heart Journal|August 31, 2024
Advanced understanding of immune mechanisms in acute myocardial infarction: coronary extracellular vesicles trigger NETosisTeresa Gerhardt, Ulf Landmesser
European Heart Journal|June 26, 2026
PCSK9 inhibition in patients without previous cardiovascular events but at high risk: the earlier the betterDavid Sinning, Ulf Landmesser
Current Cardiology Reports|October 22, 2020
Low-density Lipoprotein-Cholesterol Lowering Strategies for Prevention of Atherosclerotic Cardiovascular Disease: Focus on siRNA Treatment Targeting PCSK9 (Inclisiran)David Sinning, Ulf Landmesser
International Journal of Cardiology|September 7, 2017
Challenges in using high-sensitive troponin reporting in clinical practice-The important role of appropriate use in the context of clinical evaluationMartin Möckel, Ulf Landmesser
Pageof 74